GTBP: GT Biopharma, Inc. Stock

by  •  • Comments Off on GTBP: GT Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.89
Enterprise Value ($M) 3.81
Book Value ($M) 7.48
Book Value / Share 5.41
Price / Book 0.65
NCAV ($M) 7.42
NCAV / Share 5.38
Price / NCAV 0.66

Profitability (mra)
Return on Invested Capital (ROIC) -1.01
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 2.12
Current Ratio 2.12

Balance Sheet (mrq) ($M)
Current Assets 14.06
Assets 14.11
Liabilities 6.63
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -13.58
Net Income -7.60
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.85
Cash from Investing -2.01
Cash from Financing 6.27

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -40.83
09-19 13G Cytovance Biologics Inc 6.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 12 334 3.59
2024-04-23 315 1,395 22.58
2024-04-22 40 1,536 2.60

(click for more detail)

Similar Companies
GNLX – Genelux Corporation GNPX – Genprex, Inc.
GOVX – GeoVax Labs, Inc. GYRE – Gyre Therapeutics, Inc.
HEPA – Hepion Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io